Next-Gen Therapeutics

From precision peptide engineering to advanced antibody-drug conjugates and PROTAC research, our innovative solutions drive pharma advancements. At The CoreBio, we combine scientific expertise with cutting-edge technologies to tackle the most complex challenges in drug discovery and development.
Our commitment to innovation enables us to deliver groundbreaking therapies that improve patient outcomes and address unmet medical needs across various therapeutic areas. With a focus on collaboration and customized approaches, we ensure our partners achieve their research goals efficiently. Explore how we’re shaping the future of biopharma and redefining therapeutic possibilities.

The CoreBio's image

Peptide Engineering

Delivering tailored solutions for the design, synthesis, and optimization of peptides for various applications, including drug discovery, diagnostics, and biotechnology. Our comprehensive services encompass custom peptide synthesis, incorporating linear and cyclic peptide designs, and advanced modifications such as PEGylation, cyclization, and conjugation with biomolecules or drugs to improve therapeutic performance. We specialize in sequence optimization to enhance peptide stability, bioavailability, and resistance to enzymatic degradation, ensuring high specificity and bioactivity. Additionally, we offer purity analysis, structure-activity relationship (SAR) studies, and scale-up capabilities to support preclinical and clinical research. Partner with us to accelerate the development of innovative peptide-based solutions tailored to your specific needs.

The CoreBio's image

Antibody-Drug Conjugate (ADC) Development

Offering comprehensive solutions for the development of next-generation Antibody-Drug Conjugates (ADCs), combining expertise in monoclonal antibody selection, site-specific conjugation techniques (e.g., thiol or lysine conjugation), and linker-payload optimization. Our advanced conjugation strategies ensure precise attachment of payloads to antibodies, maximizing therapeutic efficacy while minimizing off-target toxicity. We also provide payload design and synthesis, tailored to the target biology, along with rigorous analytical characterization to ensure stability, potency, and scalability. From early-stage design to preclinical development, we partner with you to create ADCs with an enhanced therapeutic index and a strong foundation for clinical success.

The CoreBio's image

Radiochemsitry

Specialized in advanced radiochemistry services, providing cutting-edge solutions for research, development, and production in radiopharmaceuticals and nuclear medicine. Our expertise includes isotope labeling, synthesis of radioactive compounds, quality control, and regulatory support for clinical and preclinical studies. We partner with healthcare and research organizations to deliver innovative, high-quality radiochemical products that support diagnostics, therapy, and scientific discovery.